|Mr. Antony Koblish||Co-founder, Pres, CEO & Director||539.06k||N/A||1966|
|Dr. Maarten Persenaire||Co-Founder & Chief Medical Officer||402.5k||N/A||1957|
|Dr. E. Skott Greenhalgh Ph.D.||Chief Technology Officer||395.31k||N/A||1967|
|Ms. Nora E. Brennan||Chief Financial Officer||N/A||N/A||1968|
|Mr. Michael Leonard||VP of Operations||N/A||N/A||N/A|
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. It offers reinforced tissue matrix products for a variety of reconstruction procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. The company provides a portfolio of OviTex Reinforced Tissue Matrix or OviTex products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix or OviTex PRS products to address the unmet needs in plastic and reconstructive surgery. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.